bioMérieux: sets targets for 2021
(CercleFinance.com) - In its nine-month trading update, bioMérieux announces that it now estimates that its contributory current operating income should exceed 700 million euros, and no longer "in line with that of 2020 ", at current exchange rates.
Given higher-than-expected demand in Q3 for multiplex respiratory panels, annual sales are now expected to grow by 4% to 7% organically (compared to "flat to around 5%" growth previously).
The in vitro diagnostics specialist posted sales of just over 2.45 billion euros at 30 September 2021, with published growth of 8.2% and organic growth of 12.1%, thanks to a stronger-than-expected third quarter.
Copyright (c) 2021 CercleFinance.com. All rights reserved.